Home

Public Policy

The Measure of a Great Industry is Who's Listening

In June 2003, the Biotechnology Industry Organization (BIO) brought its annual convention to Washington, D.C., setting the stage for an unprecedented exchange of views and expectations between biotechnology leaders and our nation’s top public officials.

Off-Label Use of Anticancer Therapies: Physician Prescribing Trends and the Impact of Payer Coverage Policy

Providers and policy makers must collectively address the profound effect the red-tape hassle can have on the practice of oncology.

Biomass as Feedstock for a Bioenergy and Bioproducts Industry

The U.S. Department of Energy (DOE) and the U.S. Department of Agriculture (USDA) are both strongly committed to expanding the role of biomass as an energy source.

Letters, Testimony & Comments

Transatlantic Trade and Investment Partnership
May 16 2013
Introduction The Biotechnology Industry Organization (BIO) appreciates the opportunity to respond to the Request for Comments issued by...
BIO's letter to FL Governor Scott Regarding Substitution of Biosimilar Medicines
May 8 2013
The Honorable Rick Scott Office of the Governor State of Florida 400 S. Monroe St. Tallahassee, FL 32399-0001 Dear Governor Scott...
PBRER: BIO Comments on Postmarket Periodic Safety Reports in the International Conference on Harmonisation E2C(R2) Format
May 8 2013
  Dear Sir/Madam:   The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for...
Benefit-Risk: BIO Comments on FDA's Prescription Drug User Fee Act V Benefit-Risk Plan
May 7 2013
Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to...
Recombinant DNA: BIO Comments on WHO Guidelines on the Quality, Safety, and Efficacy of Biological Medicinal Products Prepared by Recombinant DNA Technology
April 19 2013
  The Biotechnology Industry Organization (BIO) appreciates the opportunity to comment on the “WHO Guidelines on the Quality...
More Letters, Testimony & Comments →

Press Releases

BIO Commends Supreme Court's Support for Continued Biotech Innovation
May 14 2013
Washington, D.C. (May 13, 2013) Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO)...
BIO Releases Bioscience Economic Development Report and Guide
April 23 2013
The Biotechnology Industry Organization (BIO) released its “Bioscience Economic Development: Legislative...
BIO Applauds Reps. Hurt and Meeks for Introducing H.R. 1564 to Avoid Burdensome Regulations
April 16 2013
Washington, D.C. (April 16, 2013) Washington, D.C. (April 16, 2013) – The Biotechnology Industry Organization...
Administration’s Budget Proposal Undercuts Development of Cures and Breakthroughs, and Hurts Job Growth
April 11 2013
Washington, D.C. (April 16, 2013) Washington, D.C. (April 16, 2013) – The Biotechnology Industry Organization...
Biosimilars Bill Seeks To Notify Patients & Doctors of Changes to Prescriptions
April 3 2013
Washington, D.C. (April 2, 2013) –  The Biotechnology Industry Organization (BIO) and BioFlorida commend...
More Press Releases →